Cytokinetics, Incorporated (CYTK)

NASDAQ: CYTK · IEX Real-Time Price · USD

64.80

-2.02 (-3.02%)

At close: Apr 25, 2024, 4:00 PM

65.00

+0.20 (0.31%)

Pre-market: Apr 26, 2024, 7:44 AM EDT

Cytokinetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2002
Cash & Equivalents	113.02	65.58	112.67	82.99	36.43	42.26	125.21	66.87	65.08	20.22	Upgrade
Short-Term Investments	501.8	717	358.97	381.08	188.68	156.48	143.69	89.38	46.37	63.01	Upgrade
Cash & Cash Equivalents	614.82	782.58	471.64	464.06	225.11	198.73	268.89	156.25	111.44	83.23	Upgrade
Cash Growth	-21.44%	65.93%	1.63%	106.15%	13.27%	-26.09%	72.09%	40.21%	33.90%	7.08%	Upgrade
Receivables	1.28	0.15	51.82	4.42	5.16	2.23	1.11	0.02	0.01	46.65	Upgrade
Other Current Assets	11.94	12.46	12.22	5.74	3.48	6.71	4.29	2.36	1.65	1.26	Upgrade
Total Current Assets	628.05	795.19	535.67	474.22	233.75	207.67	274.3	158.63	113.11	131.13	Upgrade
Property, Plant & Equipment	147.74	163.19	146.41	16.27	13.41	3.5	3.57	3.64	1.75	1.64	Upgrade
Long-Term Investments	40.53	46.71	152.05	36.95	42.65	0	16.52	7.67	0.18	0	Upgrade
Other Long-Term Assets	8	9.69	7.19	6.36	0	0	0.43	0.2	0.2	0.2	Upgrade
Total Long-Term Assets	196.27	219.59	305.65	59.58	56.06	3.5	20.52	11.51	2.13	1.84	Upgrade
Total Assets	824.32	1,015	841.32	533.8	289.81	211.18	294.81	170.14	115.24	132.97	Upgrade
Accounts Payable	21.51	25.61	21.09	8.05	8.16	3.76	5.25	4.24	2.24	1.36	Upgrade
Deferred Revenue	0	0	87	87	0	0	24.57	23.06	20.86	33.6	Upgrade
Current Debt	27.97	13.79	14.86	2.79	4.62	2.61	0	2.5	0	0	Upgrade
Other Current Liabilities	53.2	45.22	-51.09	-66.64	13.25	15.82	2.62	3.46	8.55	-11.11	Upgrade
Total Current Liabilities	102.68	84.62	71.86	31.2	26.02	22.19	32.44	33.26	31.65	23.86	Upgrade
Long-Term Debt	727.8	736.51	255.07	136.15	131.45	40.58	31.78	27.38	14.64	0	Upgrade
Other Long-Term Liabilities	380.16	301.55	270.53	253.07	143.28	122.47	120.75	15.14	0.36	17.05	Upgrade
Total Long-Term Liabilities	1,108	1,038	525.6	389.22	274.73	163.05	152.52	42.52	15	17.05	Upgrade
Total Liabilities	1,211	1,123	597.46	420.42	300.75	185.24	184.97	75.78	46.65	40.9	Upgrade
Total Debt	755.77	750.3	269.93	138.94	136.07	43.18	31.78	29.88	14.64	0	Upgrade
Debt Growth	0.73%	177.96%	94.28%	2.11%	215.09%	35.90%	6.35%	104.12%	-	-	Upgrade
Retained Earnings	-2,112.24	-1,585.99	-1,207.62	-992.31	-865.02	-743.32	-646.08	-518.29	-534.74	-497.24	Upgrade
Comprehensive Income	-0.01	-3.59	-0.87	0.15	0.68	0.5	0.34	0.14	0.15	-0	Upgrade
Shareholders' Equity	-386.32	-107.9	243.86	113.38	-10.94	25.93	109.84	94.36	68.59	92.06	Upgrade
Net Cash / Debt	-140.95	32.28	201.71	325.12	89.04	155.55	237.11	126.37	96.8	83.23	Upgrade
Net Cash / Debt Growth	-	-84.00%	-37.96%	265.13%	-42.75%	-34.40%	87.64%	30.54%	16.31%	7.08%	Upgrade
Net Cash Per Share	-1.46	0.36	2.62	5.04	1.55	2.86	4.80	2.97	2.49	2.33	Upgrade
Working Capital	525.37	710.57	463.81	443.02	207.73	185.48	241.85	125.38	81.46	107.28	Upgrade
Book Value Per Share	-4.00	-1.20	3.17	1.76	-0.19	0.48	2.22	2.36	1.77	2.58	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).